Norarman
| |
| Nazivi | |
|---|---|
| Preferisani IUPAC naziv
9-metilpirido[3,4-b]indol | |
| Drugi nazivi
9-metil-beta-karbolin • 9-metil-9h-pirido[3,4-b]indol • 2521-07-5 • 9H-Pirido[3,4-b]indol, 9-metil- • 9-Metil-9H-pirido(3,4-b)indol • 9-metilpirido[3,4-b]indol • 9-metil-beta-karbolin • 9-metilnorharman • GC837J2CCJ • 9H-Pirido(3,4-b)indol, 9-metil- • 9-Metilnorharman • N-Metilnorharman • Norharman, N-metil- • UNII-GC837J2CCJ • SCHEMBL280032 • Metil-9h-pirido[3,4-b]indol • DTXSID50179871 • MABOIYXDALNSES-UHFFFAOYSA-N • 9-METHYL-.BETA.-CARBOLINE • MFCD18803860 • AKOS025312186 • AS-61363 • PD150600 • CS-0102858 • M2818 • A904394
| |
| Identifikacija | |
3D model (Jmol)
|
|
| UNII | |
| |
| Svojstva | |
| C12H10N2 | |
| Molarna masa | 182,23 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Norarman je inhibitor monoamin oksidazu.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Sebastian Keller; et al. (2022). „Correction to: 9-Methyl-β-carboline inhibits monoamine oxidase activity and stimulates the expression of neurotrophic factors by astrocytes”. J Neural Transm (Vienna). 129 (1): 125. doi:10.1007/s00702-021-02433-w.